Why China Natural Resources Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket

Gainers

China Natural Resources, Inc. CHNR shares surged 63.5% to $3.22 in pre-market trading after the company agreed to sell all outstanding shares of Precise Space-Time Technology Limited to Feishang Group Limited, together with PSTT's outstanding payable owed to the Company, for consideration of around RMB95,761,119 in cash.
FOXO Technologies Inc. FOXO rose 45.3% to $0.1941 in pre-market trading.
Aurora Acquisition Corp. AURC gained 29.6% to $57.08 in pre-market trading after jumping 113% on Friday
Nano Labs Ltd NA shares gained 25% to $1.80 in pre-market trading after the company reported receipt of interest-free loans from shareholders.
Connexa Sports Technologies Inc. CNXA shares rose 18% to $0.1533 in pre-market trading.
Inpixon INPX shares gained 16.6% to $0.2814 in pre-market trading after jumping 19% on Friday.
Barnes & Noble Education, Inc. BNED shares climbed 16% to $1.45 in pre-market trading after the company entered into an agreement with key financial stakeholders and strategic partners to strengthen financial position and support growth initiatives.
Visionary Education Technology Holdings Group Inc. VEDU shares rose 14.5% to $0.4479 in pre-market trading after gaining 5% on Friday.
Apellis Pharmaceuticals, Inc. APLS gained 13.9% to $36.47 in pre-market trading after the company issued an update on review of rare safety events with Syfovre for geographic atrophy.
Eos Energy Enterprises, Inc. EOSE rose 11.5% to $2.52 in pre-market trading. Eos Energy Enterprises said it expects to record revenue of $0.2 million for the quarter ended June 30, 2023.

Losers

Navidea Biopharmaceuticals, Inc. NAVB fell 22.4% to $0.0737 in pre-market trading after the company announced NYSE American has commenced delisting proceedings and the company intends to appeal.
Unique Fabricating, Inc. UFAB fell 17.6% to $0.2850 in pre-market trading after gaining 60% on Friday.
Sonnet BioTherapeutics Holdings, Inc. SONN fell 16.3% to $0.2850 in pre-market trading. Sonnet BioTherapeutics, last month, announced a $2.25 million registered direct offering of 5 million at $0.45/share.
Troika Media Group, Inc. TRKA shares fell 9.7% to $2.33 in pre-market trading after gaining over 7% on Friday.
Citius Pharmaceuticals, Inc. CTXR fell 9% to $1.02 in pre-market trading after the company received FDA Complete Response Letter for Lymphir (Denileukin Diftitox) for relapsed/refractory cutaneous T-cell lymphoma.
Satixfy Communications Ltd. SATX shares fell 9.6% to $0.2985 in pre-market trading. SatixFy Communications recently named Mr. Nir Barkan as Acting Chief Executive Officer.
BioNexus Gene Lab Corp. BGLC fell 8.7% to $2.74 in pre-market after jumping over 40% on Friday.
Akari Therapeutics, Plc AKTX fell 8.2% to $0.2001 in pre-market trading. Akari Therapeutics was recently granted Nomacopan Orphan Drug Designation from the European Commission for treatment in hematopoietic stem cell transplantation.
Greenbrook TMS Inc. GBNH shares fell 6.8% to $0.4685 in pre-market trading.
Femasys Inc. FEMY fell 6.8% to $0.6061 in pre-market trading after dipping over 22% on Friday.